医学
组织微阵列
免疫组织化学
肿瘤科
头颈部鳞状细胞癌
淋巴结
头颈部癌
PD-L1
基底细胞
阶段(地层学)
内科学
下调和上调
原发性肿瘤
头颈部
癌症
癌
病理
转移
免疫疗法
基因
外科
生物
古生物学
生物化学
作者
Julius Moratin,Karl Metzger,Ayse Safaltin,Esther Herpel,Jürgen Hoffmann,Kolja Freier,Jochen Heß,Dominik Horn
出处
期刊:Head & neck
[Wiley]
日期:2019-03-01
卷期号:41 (8): 2484-2491
被引量:30
摘要
This study aimed on evaluating the expression levels of the immune checkpoint proteins, PD-L1 and PD-L2, in tissue specimens of 175 oral squamous cell carcinomas (OSCC) and 33 corresponding lymph node metastases (LNM).Tissue microarrays of primary OSCC and matched LNM were investigated via immunohistochemistry regarding PD-L1/PD-L2 expression. Results were compared for primary tumors and corresponding metastases and correlated with clinicopathological data.PD-L1 expression in cancer cells correlated significantly with tumor size, and the presence of regional metastases (P < 0.01). PD-L1 expression was significantly higher in metastases as compared to primary OSCC (P < 0.05). Overall survival was significantly worse in patients with higher levels of PD-L1 and PD-L2 score (P < 0.05).This is the first publication to compare PD-L1 and PD-L2 expression in primary OSCC and matched LNM. The results indicate that anti-PD-1 therapy may be of therapeutic use even in early stage OSCC to prevent further progression.
科研通智能强力驱动
Strongly Powered by AbleSci AI